Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation

dc.contributor.authorHe, Zhengcheng
dc.contributor.authorGhorayeb, Ryan
dc.contributor.authorTan, Susanna
dc.contributor.authorChen, Ke
dc.contributor.authorLorentzian, Amanda C.
dc.contributor.authorBottyan, Jack
dc.contributor.authorAalam, Syed Mohammed Musheer
dc.contributor.authorPujana Genestar, M. Ángel
dc.contributor.authorLange, Philipp F.
dc.contributor.authorKannan, Nagarajan
dc.contributor.authorEaves, Connie J.
dc.contributor.authorMaxwell, Christopher A.
dc.date.accessioned2022-05-13T08:38:00Z
dc.date.available2022-05-13T08:38:00Z
dc.date.issued2022-04-22
dc.date.updated2022-05-12T10:40:59Z
dc.description.abstractFemale carriers of BRCA1 mutations possess high breast cancer risk, which may reflect deficient growth control of mammary progenitor cells. Here, the authors study progenitor-enriched fractions from these carriers and describe a loss of PLK1-mediated mitotic spindle positioning and an inability of the progeny to acquire features of mature luminal cells. Preneoplastic mammary tissues from human female BRCA1 mutation carriers, or Brca1-mutant mice, display unexplained abnormalities in luminal differentiation. We now study the division characteristics of human mammary cells purified from female BRCA1 mutation carriers or non-carrier donors. We show primary BRCA1 mutant/+ cells exhibit defective BRCA1 localization, high radiosensitivity and an accelerated entry into cell division, but fail to orient their cell division axis. We also analyse 15 genetically-edited BRCA1 mutant/+ human mammary cell-lines and find that cells carrying pathogenic BRCA1 mutations acquire an analogous defect in their division axis accompanied by deficient expression of features of mature luminal cells. Importantly, these alterations are independent of accumulated DNA damage, and specifically dependent on elevated PLK1 activity induced by reduced BRCA1 function. This essential PLK1-mediated role of BRCA1 in controlling the cell division axis provides insight into the phenotypes expressed during BRCA1 tumorigenesis.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2041-1723
dc.identifier.pmid35459234
dc.identifier.urihttps://hdl.handle.net/2445/185523
dc.language.isoeng
dc.publisherSpringer
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41467-022-29885-2
dc.relation.ispartofNature Communications, 2022, vol. 13, num. 1
dc.relation.urihttps://doi.org/10.1038/s41467-022-29885-2
dc.rightscc by (c) He, Zhengcheng et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationTumors
dc.subject.classificationMama
dc.subject.otherTumors
dc.subject.otherBreast
dc.titlePathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s41467-022-29885-2.pdf
Mida:
4.12 MB
Format:
Adobe Portable Document Format